STATCRISPR hits a snag: Our immune systems may attack the treatmentSTATnew paper points to a previously unknown hurdle for scientists racing to develop therapies using the revolutionary genome-editing tool CRISPR-Cas9 1: the human immune system. In a s… Continue reading
Harvard Medical School |
Cracking Tumor Defiance
Harvard Medical School The scientists’ curiosity was piqued by the fact that ccRCC differs from other types of cancer that respond well to immunotherapy, such as melanoma, non-small cell lung cancer and a specific type of colorectal cancer. Cells of the latter cancer types … |
|
New biomarkers predict outcome of cancer immunotherapy
Science Daily Nowadays, melanoma and lung cancer can be combatted effectively through immunotherapy, which makes targeted use of the immune system’s normal function of regularly examining the body’s tissue for pathogens and damages. Specific inhibitors are used to … |
JAPAN Forward (press release) (blog) |
Nobel Prize Doctor Yamanaka: Stem Cell Progress ‘Just the Beginning’
JAPAN Forward (press release) (blog) iPS cells have been a catalyst to research that use embryonic stem cells (ES cells). I cannot take all the credit because I wouldn’t have made it this far without the efforts of everyone involved. I always remind myself how grateful I should be … 8K footage of iPS becoming cardiac muscleNHK WORLD |